Annual Net Income
-$4.51 M
+$22.24 M+83.15%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual net profit is -$4.51 million, with the most recent change of +$22.24 million (+83.15%) on December 31, 2023.
- During the last 3 years, SBFM annual net income has fallen by -$1.72 million (-61.85%).
- SBFM annual net income is now -34296.95% below its all-time high of -$13.10 thousand, reached on July 1, 2007.
Performance
SBFM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$1.20 M
-$703.50 K-142.32%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly net profit is -$1.20 million, with the most recent change of -$703.50 thousand (-142.32%) on September 30, 2024.
- Over the past year, SBFM quarterly net income has dropped by -$546.30 thousand (-83.85%).
- SBFM quarterly net income is now -279.55% below its all-time high of $667.10 thousand, reached on December 1, 2021.
Performance
SBFM Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$4.23 M
-$546.30 K-14.85%
September 30, 2024
Summary
- As of February 7, 2025, SBFM TTM net profit is -$4.23 million, with the most recent change of -$546.30 thousand (-14.85%) on September 30, 2024.
- Over the past year, SBFM TTM net income has increased by +$22.54 million (+84.21%).
- SBFM TTM net income is now -47921.59% below its all-time high of -$8800.00, reached on October 1, 2007.
Performance
SBFM TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
SBFM Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +83.2% | -83.8% | +84.2% |
| 3 y3 years | -61.9% | -32.8% | +84.7% |
| 5 y5 years | -109.0% | -32.8% | +84.7% |
SBFM Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.2% | -279.6% | +94.9% | -64.8% | +84.7% |
| 5 y | 5-year | -171.4% | +83.2% | -279.6% | +94.9% | -172.3% | +84.7% |
| alltime | all time | <-9999.0% | +83.2% | -279.6% | +94.9% | <-9999.0% | +84.7% |
Sunshine Biopharma Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.20 M(+142.3%) | -$4.23 M(+14.8%) |
| Jun 2024 | - | -$494.30 K(-61.5%) | -$3.68 M(-10.0%) |
| Mar 2024 | - | -$1.28 M(+2.7%) | -$4.09 M(-9.3%) |
| Dec 2023 | -$4.51 M(-83.2%) | -$1.25 M(+91.9%) | -$4.51 M(-83.2%) |
| Sep 2023 | - | -$651.50 K(-27.8%) | -$26.77 M(-2.9%) |
| Jun 2023 | - | -$902.10 K(-47.0%) | -$27.57 M(+1.3%) |
| Mar 2023 | - | -$1.70 M(-92.8%) | -$27.21 M(+1.7%) |
| Dec 2022 | -$26.74 M(+115.0%) | -$23.51 M(+1513.7%) | -$26.74 M(+942.7%) |
| Sep 2022 | - | -$1.46 M(+170.4%) | -$2.56 M(-50.2%) |
| Jun 2022 | - | -$538.90 K(-56.4%) | -$5.15 M(-31.3%) |
| Mar 2022 | - | -$1.24 M(-285.3%) | -$7.49 M(-39.8%) |
| Dec 2021 | -$12.44 M(+346.7%) | - | - |
| Dec 2021 | - | $667.10 K(-116.5%) | -$12.44 M(-12.3%) |
| Sep 2021 | - | -$4.04 M(+40.3%) | -$14.19 M(+30.8%) |
| Jun 2021 | - | -$2.88 M(-53.5%) | -$10.85 M(+22.2%) |
| Mar 2021 | - | -$6.19 M(+470.7%) | -$8.87 M(+218.8%) |
| Dec 2020 | -$2.78 M(+67.7%) | -$1.08 M(+55.1%) | -$2.78 M(+32.8%) |
| Sep 2020 | - | -$698.60 K(-23.0%) | -$2.10 M(+19.9%) |
| Jun 2020 | - | -$907.40 K(+862.2%) | -$1.75 M(+12.7%) |
| Mar 2020 | - | -$94.30 K(-76.2%) | -$1.55 M(-6.5%) |
| Dec 2019 | -$1.66 M(-23.0%) | -$396.60 K(+13.2%) | -$1.66 M(+3.6%) |
| Sep 2019 | - | -$350.20 K(-50.7%) | -$1.60 M(-25.8%) |
| Jun 2019 | - | -$710.90 K(+251.1%) | -$2.16 M(+3.2%) |
| Mar 2019 | - | -$202.50 K(-40.2%) | -$2.09 M(-2.9%) |
| Dec 2018 | -$2.16 M(+107.3%) | -$338.70 K(-62.7%) | -$2.16 M(+6.3%) |
| Sep 2018 | - | -$907.60 K(+40.9%) | -$2.03 M(+59.9%) |
| Jun 2018 | - | -$644.30 K(+142.6%) | -$1.27 M(+14.3%) |
| Mar 2018 | - | -$265.60 K(+25.6%) | -$1.11 M(+6.7%) |
| Dec 2017 | -$1.04 M(-70.3%) | -$211.50 K(+43.3%) | -$1.04 M(-46.7%) |
| Sep 2017 | - | -$147.60 K(-69.6%) | -$1.95 M(-42.4%) |
| Jun 2017 | - | -$485.40 K(+148.0%) | -$3.39 M(+0.1%) |
| Mar 2017 | - | -$195.70 K(-82.6%) | -$3.39 M(-3.1%) |
| Dec 2016 | -$3.50 M | -$1.12 M(-29.1%) | -$3.50 M(+15.8%) |
| Sep 2016 | - | -$1.59 M(+229.4%) | -$3.02 M(+84.5%) |
| Jun 2016 | - | -$481.30 K(+57.6%) | -$1.64 M(-2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$305.30 K(-52.9%) | -$1.67 M(+0.7%) |
| Dec 2015 | -$1.65 M(-14.5%) | -$647.70 K(+219.4%) | -$1.66 M(+23.3%) |
| Sep 2015 | - | -$202.80 K(-60.8%) | -$1.35 M(-5.5%) |
| Jun 2015 | - | -$517.50 K(+75.8%) | -$1.43 M(-14.8%) |
| Mar 2015 | - | -$294.40 K(-11.8%) | -$1.67 M(-11.0%) |
| Dec 2014 | -$1.93 M(-22.4%) | -$333.70 K(+18.8%) | -$1.88 M(-15.8%) |
| Sep 2014 | - | -$280.80 K(-63.3%) | -$2.23 M(+4.8%) |
| Jun 2014 | - | -$765.50 K(+52.7%) | -$2.13 M(+40.3%) |
| Mar 2014 | - | -$501.30 K(-26.9%) | -$1.52 M(-39.1%) |
| Dec 2013 | -$2.49 M(+251.9%) | -$685.80 K(+285.1%) | -$2.49 M(+24.9%) |
| Sep 2013 | - | -$178.10 K(+16.4%) | -$2.00 M(-9.0%) |
| Jun 2013 | - | -$153.00 K(-89.6%) | -$2.20 M(+2.3%) |
| Mar 2013 | - | -$1.48 M(+682.4%) | -$2.15 M(+203.1%) |
| Dec 2012 | -$708.00 K(+27.3%) | -$188.80 K(-49.9%) | -$708.00 K(-20.6%) |
| Sep 2012 | - | -$376.80 K(+265.5%) | -$891.30 K(+41.3%) |
| Jun 2012 | - | -$103.10 K(+162.3%) | -$630.90 K(+15.9%) |
| Mar 2012 | - | -$39.30 K(-89.4%) | -$544.30 K(-1.8%) |
| Dec 2011 | -$556.20 K(+3.5%) | -$372.10 K(+219.7%) | -$554.20 K(-0.9%) |
| Sep 2011 | - | -$116.40 K(+605.5%) | -$559.00 K(-7.3%) |
| Jun 2011 | - | -$16.50 K(-66.5%) | -$603.00 K(-72.3%) |
| Mar 2011 | - | -$49.20 K(-86.9%) | -$2.17 M(-1.6%) |
| Dec 2010 | -$537.40 K(-55.3%) | -$376.90 K(+135.0%) | -$2.21 M(+20.6%) |
| Sep 2010 | - | -$160.40 K(-89.9%) | -$1.83 M(-34.7%) |
| Jun 2010 | - | -$1.59 M(+1777.2%) | -$2.81 M(+128.8%) |
| Mar 2010 | - | -$84.60 K(-92.5%) | -$1.23 M(+6.5%) |
| Dec 2009 | -$1.20 M(+4704.4%) | - | - |
| Oct 2009 | - | -$1.13 M(>+9900.0%) | -$1.15 M(+4488.0%) |
| Jul 2009 | -$25.00 K(-19.6%) | -$8800.00(+49.2%) | -$25.10 K(+14.6%) |
| Apr 2009 | - | -$5900.00(+55.3%) | -$21.90 K(-28.0%) |
| Jan 2009 | - | -$3800.00(-42.4%) | -$30.40 K(+5.2%) |
| Oct 2008 | - | -$6600.00(+17.9%) | -$28.90 K(-7.1%) |
| Jul 2008 | -$31.10 K(+137.4%) | -$5600.00(-61.1%) | -$31.10 K(+22.0%) |
| Apr 2008 | - | -$14.40 K(+526.1%) | -$25.50 K(+129.7%) |
| Jan 2008 | - | -$2300.00(-73.9%) | -$11.10 K(+26.1%) |
| Oct 2007 | - | -$8800.00 | -$8800.00 |
| Jul 2007 | -$13.10 K | - | - |
FAQ
- What is Sunshine Biopharma annual net profit?
- What is the all time high annual net income for Sunshine Biopharma?
- What is Sunshine Biopharma annual net income year-on-year change?
- What is Sunshine Biopharma quarterly net profit?
- What is the all time high quarterly net income for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly net income year-on-year change?
- What is Sunshine Biopharma TTM net profit?
- What is the all time high TTM net income for Sunshine Biopharma?
- What is Sunshine Biopharma TTM net income year-on-year change?
What is Sunshine Biopharma annual net profit?
The current annual net income of SBFM is -$4.51 M
What is the all time high annual net income for Sunshine Biopharma?
Sunshine Biopharma all-time high annual net profit is -$13.10 K
What is Sunshine Biopharma annual net income year-on-year change?
Over the past year, SBFM annual net profit has changed by +$22.24 M (+83.15%)
What is Sunshine Biopharma quarterly net profit?
The current quarterly net income of SBFM is -$1.20 M
What is the all time high quarterly net income for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly net profit is $667.10 K
What is Sunshine Biopharma quarterly net income year-on-year change?
Over the past year, SBFM quarterly net profit has changed by -$546.30 K (-83.85%)
What is Sunshine Biopharma TTM net profit?
The current TTM net income of SBFM is -$4.23 M
What is the all time high TTM net income for Sunshine Biopharma?
Sunshine Biopharma all-time high TTM net profit is -$8800.00
What is Sunshine Biopharma TTM net income year-on-year change?
Over the past year, SBFM TTM net profit has changed by +$22.54 M (+84.21%)